Korean J Intern Med.
2013 Mar;28(2):159-161. 10.3904/kjim.2013.28.2.159.
Patients treated with a tumor necrosis factor-alpha inhibitor are more likely to develop extrapulmonary tuberculosis
- Affiliations
-
- 1Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea. soleemd@amc.seoul.kr
- KMID: 1501769
- DOI: http://doi.org/10.3904/kjim.2013.28.2.159
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Tuberculous Arthritis Following the Use of Etanercept
- Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-alpha inhibitor
- A Case of Invasive Pulmonary Aspergillosis in a Patient with Rheumatoid Arthritis Treated with Adalimumab
- Guidelines for Prevention of Tuberculosis in Patients with Rheumatoid Arthritis Treated with TNF-alpha Blockers
- Rituximab for Rheumatoid Arthritis Following TNF-alpha Inhibitor Associated Splenic Tuberculosis
